Opiant Pharmaceuticals, Inc.
OPNTDelisted Mar 2, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001385508
Opiant Pharmaceuticals, Inc. was delisted on Mar 2, 2023; its insiders filed their last Form 4 on Mar 3, 2023; 37 institutions reported holding it in 13F filings for Q4 2022, worth $43.2M in total; no superinvestor held it.
13F holders, Q4 2021
Institutional positions in Opiant Pharmaceuticals, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 42
- +7 vs. Q3 2021
- Shares held
- 1.42M
- +146.4K (+11.5%) vs. Q3 2021
- Total value
- $47.6M
- +$14.9M (+45.7%) vs. Q3 2021
- New holders
- 11
- 11 more added
- Sold out
- 4
- 9 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting OPNT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 37 | $43.2M |
| Q3 2022 | 32 | $19.4M |
| Q2 2022 | 33 | $22.3M |
| Q1 2022 | 41 | $33.3M |
| Q4 2021 | 42 | $47.6M |
| Q3 2021 | 35 | $32.7M |
| Q2 2021 | 26 | $11.8M |
| Q1 2021 | 31 | $9.70M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Opiant Pharmaceuticals, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Sage Private Wealth Group, LLC | 5 | $0 | 0.00% | 00.0% | Unchanged |
| Federated Hermes, Inc. | 63 | $2.00K | 0.00% | 00.0% | Unchanged |
| National Bank of Canada | 100 | $3.00K | 0.00% | +100 | New |
| Retirement Planning Co of New England, Inc. | 180 | $6.00K | 0.00% | +180 | New |
| Federation des caisses Desjardins du Quebec | 180 | $6.05K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 252 | $8.00K | 0.00% | −13−4.9% | Reduced |
| CoreCap Advisors, LLC | 266 | $9.00K | 0.00% | +266 | New |
| UBS Group AG | 305 | $10.0K | 0.00% | −133−30.4% | Reduced |
| American Research & Management Co. | 300 | $10.0K | 0.00% | 00.0% | Unchanged |
| TAP Consulting, LLC | 471 | $16.0K | 0.00% | +471 | New |
| Lindbrook Capital, LLC | 500 | $17.0K | 0.00% | 00.0% | Unchanged |
| Spire Wealth Management | 500 | $17.0K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 1,200 | $40.0K | 0.00% | 00.0% | Unchanged |
| Newbridge Financial Services Group, Inc. | 1,850 | $62.0K | 0.03% | −300−14.0% | Reduced |
| Dorsey Wright & Associates | 2,138 | $72.0K | 0.01% | +2,138 | New |
| Hillsdale Investment Management Inc. | 3,200 | $108.0K | 0.01% | +3,200 | New |
| Marquette Asset Management, LLC | 5,180 | $174.0K | 0.04% | −2,761−34.8% | Reduced |
| Cubist Systematic Strategies, LLC | 6,417 | $216.0K | 0.00% | +6,417 | New |
| JPMorgan Chase & Co | 6,743 | $227.0K | 0.00% | +5,584+481.8% | Added |
| Bank of New York Mellon Corp | 7,803 | $262.0K | 0.00% | +7,803 | New |
| Advisor Group Holdings, Inc. | 8,125 | $273.0K | 0.00% | +1,800+28.5% | Added |
| Bridgeway Capital Management, LLC | 10,400 | $350.0K | 0.01% | 00.0% | Unchanged |
| State Street Corp | 12,000 | $404.0K | 0.00% | +12,000 | New |
| Bailard, Inc. | 16,242 | $546.0K | 0.02% | 00.0% | Unchanged |
| Marshall Wace, LLP | 23,577 | $793.0K | 0.00% | +23,577 | New |
| DLD Asset Management, LP | 30,000 | $1.01M | 0.09% | +30,000 | New |
| Essex Investment Management Co LLC | 31,263 | $1.05M | 0.12% | +6,471+26.1% | Added |
| Parkman Healthcare Partners LLC | 31,291 | $1.05M | 0.24% | +1,291+4.3% | Added |
| Perritt Capital Management Inc | 32,000 | $1.08M | 0.56% | 00.0% | Unchanged |
| Morgan Stanley | 34,336 | $1.15M | 0.00% | +18,547+117.5% | Added |
| BlackRock Inc. | 34,744 | $1.17M | 0.00% | +10,058+40.7% | Added |
| Northern Trust Corp | 37,850 | $1.27M | 0.00% | −48−0.1% | Reduced |
| EAM Investors, LLC | 44,771 | $1.51M | 0.25% | −24,275−35.2% | Reduced |
| Geode Capital Management, LLC | 50,244 | $1.69M | 0.00% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 64,057 | $2.15M | 0.01% | +13,012+25.5% | Added |
| Dimensional Fund Advisors LP | 66,651 | $2.24M | 0.00% | +22,543+51.1% | Added |
| Acadian Asset Management LLC | 71,916 | $2.42M | 0.01% | +7,475+11.6% | Added |
| Two Sigma Advisers, LP | 82,400 | $2.77M | 0.01% | −700−0.8% | Reduced |
| Apis Capital Advisors, LLC | 110,000 | $3.70M | 4.10% | +8,000+7.8% | Added |
| Vanguard Group Inc | 178,459 | $6.00M | 0.00% | +40,689+29.5% | Added |
| Renaissance Technologies LLC | 183,815 | $6.18M | 0.01% | −21,800−10.6% | Reduced |
| Wells Fargo & Company | 224,297 | $7.54M | 0.00% | −23,195−9.4% | Reduced |
| Rothschild & Co Wealth Management UK Ltd | 0 | $0 | 0.00% | −1,419−100.0% | Sold out |
| ClariVest Asset Management LLC | 0 | $0 | 0.00% | −366−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −138−100.0% | Sold out |
| O'Shaughnessy Asset Management, LLC | 0 | $0 | 0.00% | −41−100.0% | Sold out |